Ultrasound Ablation in Advanced Pancreatic Cancer Patients – What should be the Next Step?

Authors

  • Dobromir Dimitrov Surgeon (Consultant) in Surgery Department St. Marina Hopsital, Medical University-Pleven, Bulgaria
  • Hyuliya Feradova Surgeon (Consultant) in Surgery Department St. Marina Hopsital, Medical University-Pleven, Bulgaria
  • Milka Marinova Department of Radiology, Medical School & Hospital, University of Bonn, Germany
  • Zhou Kun Clinical Center for Tumor Therapy, The Second Affiliated Hospital, Chongqing Medical Uni-versity, Chongqing, China

DOI:

https://doi.org/10.17140/POJ-1-103

Keywords:

patients’ quality of life was improved which emphasizes

Abstract

In the last decades the treatment for many diseases has changed dramatically. Open surgery procedures with high morbidity and complication rates, suboptimal clinical results based on large impairment for the patients were replaced by drug treatment or minimally in-vasive techniques. Examples such as interventional cardiology procedures in acute myocardial infarction, interventional endoscopies in the treatment of hepato-biliary tract diseases, eradica-tion of Helicobacter pylori for gastric ulcer using drugs are good evidence that the words of William Osler “Diseases that harm require therapies that harm less” are valid now-a-days.

References

William S, Lee HL, Ahlering TE. Robotic surgery: review of prostate and bladder cancer. The Cancer Journal. 2013; 19(2): 133- 139. doi: 10.1097/PPO.0b013e318289dbd5

He J, Page AJ, Weiss M, et al. Management of borderline and locally advanced pancreatic cancer: where do we stand? World Journal of Gastroenterology. 2014, 20(9): 2255-2266. doi: 10.3748/wjg.v20.i9.2255

Ghosn M, Kourie HR, El Karak F, et al. Optimum chemotherapy in the management of metastatic pancreatic cancer. World Jour-nal of Gastroenterology. 2014, 20(9): 2352-2357. doi: 10.3748/wjg.v20.i9.2352

Zhang L, Wang ZB. High-intensity focused ultrasound tumor ablation: review of ten years of clinical experience. Front Med China. 2010; 4(3): 294-302. doi: 10.1007/s11684-010-0092-8

Sung HY, Jung SE, Cho SH, et al. Long-Term outcome of high-intensity focused ultrasound in advanced pancreatic cancer [J]. Pancreas. 2011, 40(7): 1080-1086. doi: 10.1097/MPA.0b013e31821fde24

Wang K, Chen L, Meng Z, et al. High intensity focused ultrasound treatment for patients with advanced pancreatic cancer: a pre-liminary dosimetric analysis. International Journal of Hyperthermia. 2012, 28(7): 645-652. doi: 10.3109/02656736.2012.713541

Orsi F, Zhang L, Arnone P, et al. High-Intensity focused ultrasound ablation: effective and safe therapy for solid tumors in difficult locations [J]. American Journal of Roentgenology. 2010; 195: W245-W252. doi: 10.2214/AJR.09.3321

Vidal-Jove J, Perich E, Jaen A, del Castillo MA. Ultrasound guided high intensity focused ultrasound (USgHIFU) for malignant tumors: survival advantage in stage III and IV pancreatic cancer. Journal of Therapeutic Ultrasound. 2015; 3(Suppl 1): O79. doi: 10.1186/2050-5736-3-S1-O79

Bob P, Ball C, Badenoch D, Straus S, Haynes B, Dawes M. Oxford centre for evidence-based medicine levels of evidence. BJU international. 2009, 103(08): 1147. Pancreas Open J Page 8

Downloads

Published

2025-09-08

How to Cite

Dobromir Dimitrov, Hyuliya Feradova, Milka Marinova, & Zhou Kun. (2025). Ultrasound Ablation in Advanced Pancreatic Cancer Patients – What should be the Next Step?. Pancreas, 1(1), 7–8. https://doi.org/10.17140/POJ-1-103

Issue

Vol. 1 No. 1 (2015): Volume 1 Issue 1 2015

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

All content published in Pancreas (POJ) is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows anyone to copy, distribute, transmit, and adapt the work — including for commercial purposes — provided appropriate credit is given to the original author(s) and source.